These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis. Wall JS; Kennel SJ; Paulus MJ; Gleason S; Gregor J; Baba J; Schell M; Richey T; O'Nuallain B; Donnell R; Hawkins PN; Weiss DT; Solomon A Amyloid; 2005 Sep; 12(3):149-56. PubMed ID: 16194869 [TBL] [Abstract][Full Text] [Related]
10. Visualization of multiple organ amyloid involvement in systemic amyloidosis using Ezawa N; Katoh N; Oguchi K; Yoshinaga T; Yazaki M; Sekijima Y Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):452-461. PubMed ID: 28891012 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies. Solomon A; Weiss DT; Wall JS Cancer Biother Radiopharm; 2003 Dec; 18(6):853-60. PubMed ID: 14969598 [TBL] [Abstract][Full Text] [Related]
12. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value. Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684 [TBL] [Abstract][Full Text] [Related]
13. The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract. Shah PL; Gillmore JD; Copley SJ; Collins JV; Wells AU; du Bois RM; Hawkins PN; Nicholson AG Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):134-42. PubMed ID: 12102609 [TBL] [Abstract][Full Text] [Related]
14. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. Antoni G; Lubberink M; Estrada S; Axelsson J; Carlson K; Lindsjö L; Kero T; Långström B; Granstam SO; Rosengren S; Vedin O; Wassberg C; Wikström G; Westermark P; Sörensen J J Nucl Med; 2013 Feb; 54(2):213-20. PubMed ID: 23238792 [TBL] [Abstract][Full Text] [Related]
15. Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis. Edwards CV; Rao N; Bhutani D; Mapara M; Radhakrishnan J; Shames S; Maurer MS; Leng S; Solomon A; Lentzsch S; Eisenberger A Blood; 2021 Dec; 138(25):2632-2641. PubMed ID: 34521113 [TBL] [Abstract][Full Text] [Related]
16. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis. Hachulla E; Maulin L; Deveaux M; Facon T; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Hatron PY; Huglo D; Devulder B; Marchandise X Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719 [TBL] [Abstract][Full Text] [Related]
17. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer. de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020 [TBL] [Abstract][Full Text] [Related]
18. AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils. Wall JS; Kennel SJ; Williams A; Richey T; Stuckey A; Huang Y; Macy S; Donnell R; Barbour R; Seubert P; Schenk D PLoS One; 2012; 7(12):e52686. PubMed ID: 23300743 [TBL] [Abstract][Full Text] [Related]
19. Amyloid PET imaging in cardiac amyloidosis: a pilot study using Dietemann S; Nkoulou R Ann Nucl Med; 2019 Aug; 33(8):624-628. PubMed ID: 31140154 [TBL] [Abstract][Full Text] [Related]